Originally published by our sister publication Infectious Disease Special Edition
By IDSE News Staff
The FDA has approved a new COVID-19 vaccine from Moderna, mNEXSPIKE (mRNA-1283).
The vaccine is indicated for people older than 65 years of age or those 12 between 64 years who have one underlying risk factor as described by the CDC.
The approval follows positive results of the vaccination’s randomized, observer-blind, active-controlled phase 3 trial (ClinicalTrials.gov Identifier: